Market Overview

The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031).

The global Nucleic Acid Therapeutics CDMO market continues to evolve rapidly, driven by shifting consumer trends, rising investments, and technological progress. This section provides a detailed snapshot of the current landscape, highlighting major developments, emerging opportunities, and competitive movements that are shaping the industry’s growth trajectory.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart): https://straitsresearch.com/report/nucleic-acid-therapeutics-cdmo-market/request-sample

Market Report Scope and Research Methodology

This report offers a balanced combination of qualitative and quantitative analysis to ensure accurate, transparent, and comprehensive insights. The scope defines the parameters and key categories of the market, helping readers clearly understand its framework and underlying dynamics.

The study examines market size, forecasts, and growth potential by analyzing crucial segments and sub-segments. It delves into the factors influencing the market—such as cost efficiency, regulatory initiatives, sustainability goals, and continuous innovation. In addition, it evaluates competitive landscapes, investment flows, and the policy environment impacting overall industry development.

Market Regional Insights

The regional analysis spans North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Each region is assessed based on market share, growth prospects, trade movements, and investment attractiveness. By studying regional demand trends, industrial performance, and government support measures, the report delivers a holistic understanding of how the market is evolving across different geographies.

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart): https://straitsresearch.com/report/nucleic-acid-therapeutics-cdmo-market/request-sample

Market Segmentation

1. By Product
   1. Standard Nucleic Acid
   2. Micro-Scale Nucleic Acid
   3. Large-Scale Nucleic Acid
   4. Custom Nucleic Acid
   5. Modified Nucleic Acid
   6. Primers
   7. Probes
   8. Other Nucleic Acid
   9. Other Services
2. By Chemical Synthesis
   1. Solid-Phase Oligonucleotide Synthesis
   2. Liquid-Phase Oligonucleotide Synthesis
3. By Technology
   1. Column-Based Method
   2. Microarray-Based Method
4. By End-User
   1. Pharmaceutical Companies
   2. Academic Research Institute
   3. Diagnostic Laboratories

Market Key Players

1. Bachem Holding AG
2. Biospring GmbH
3. Danaher Corporation
4. Guangzhou Ruibo Biotechnology Co.Ltd.
5. LGC Limited
6. Merck KGaA
7. Nippon Shokubai Co.Ltd.
8. QIAGEN N.V.
9. ST Pharm Co Ltd
10. Nitto Denko Avecia Inc.
11. Sumitomo Chemical Co.Ltd.
12. Thermo Fisher Scientific Inc.
13. Wuxi AppTec
14. Syngene International Limited

Download Exclusive Research Report PDF Sample: (Including Full TOC, List of Tables & Figures, Chart): https://straitsresearch.com/report/nucleic-acid-therapeutics-cdmo-market/request-sample

Key Questions Answered in the Nucleic Acid Therapeutics CDMO Market Report:

• How large is the Nucleic Acid Therapeutics CDMO market currently?

• What is the projected size of the Nucleic Acid Therapeutics CDMO market in the coming years?

• What is the estimated global value of the Nucleic Acid Therapeutics CDMO market?

• How fast is the Nucleic Acid Therapeutics CDMO market growing?

• Which segment accounts for the highest share in the Nucleic Acid Therapeutics CDMO market?

• What are the major Nucleic Acid Therapeutics CDMO market segments?

• What was the market value of Nucleic Acid Therapeutics CDMO in North America in 2024?

• Which region currently dominates the market landscape?

• What factors are driving the growth of the Nucleic Acid Therapeutics CDMO market?

• Who are the prominent players in the Nucleic Acid Therapeutics CDMO market?

• Which companies are leading in the Nucleic Acid Therapeutics CDMO industry?

About Straits Research

Straits Research provides comprehensive market intelligence and actionable insights across a wide range of industries. Our reports are designed to empower decision-makers, investors, and organizations to uncover growth opportunities, overcome challenges, and build strategies that ensure long-term success in a rapidly changing business environment.

"